Vanda Contests FDA Rejection of Gastroparesis Drug, Slams ‘Delayed’ Decision
Vanda Pharmaceuticals on Thursday announced that the regulator declined to approve its application, a decision the company says was delayed by more than 185 days and failed to satisfy the requirements of the Federal Drug and Cosmetic Act.
Vanda Contests FDA Rejection of Gastroparesis Drug, Slams ‘Delayed’ Decision Read More »
